Emerging from stealth, the company is debuting NEXUS, a Large Tabular Model (LTM) designed to treat business data not as a simple sequence of words, but as a complex web of non-linear relationships.

Emerging from stealth, the company is debuting NEXUS, a Large Tabular Model (LTM) designed to treat business data not as a ...

Through its proprietary LTM, ‘NEXUS’, Fundamental reveals the hidden language of tables to unlock trillions of dollars in enterprise value, while a strategic partnership with AWS accelerates adoption ...

Since the dawn of the computer age, researchers have wrestled with two persistent challenges: how to store ever-increasing ...

To finance that effort, Musk combined SpaceX with his AI business on Monday and plans a big initial public offering of the ...

Condensed-matter physics and materials science have a silo problem. Although researchers in these fields have access to vast amounts of data – from experimental records of crystal structures and ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

What really happens after you hit enter on that AI prompt? WSJ’s Joanna Stern heads inside a data center to trace the journey and then grills up some steaks to show just how much energy it takes to ...